TCL Archive EGFR Inhibitor Shrinks Tumors In Phase I Study of Patients With Treatment-Resistant Mutation May 30, 2014
TCL Archive Cell Genesys Begins Phase II Trial Of Gvax Vaccine For Pancreatic Cancer. November 30, 2001
TCL Archive Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease October 31, 2014
TCL Archive Guest Editorial: Even Slam-Dunk Applications Can Benefit From Public Scrutiny and Discussion at ODAC August 10, 2012